Post-translational modifications and the Warburg effect

被引:109
|
作者
Hitosugi, T. [1 ]
Chen, J. [2 ]
机构
[1] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN USA
[2] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst Emory, Atlanta, GA 30322 USA
关键词
the Warburg effect; post-translational modifications; cancer metabolism; PYRUVATE-KINASE M2; PHOSPHOGLYCERATE MUTASE; TYROSINE PHOSPHORYLATION; NUCLEAR TRANSLOCATION; LACTATE-DEHYDROGENASE; GLYCOLYTIC-ENZYMES; METABOLIC TRANSFORMATION; GENE-TRANSCRIPTION; 3T3-L1; ADIPOCYTES; CELL METABOLISM;
D O I
10.1038/onc.2013.406
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Post-translational modification (PTM) is an important step of signal transduction that transfers chemical groups such as phosphate, acetyl and glycosyl groups from one protein to another protein. As most of the PTMs are reversible, normal cells use PTMs as a 'switch' to determine the resting and proliferating state of cells that enables rapid and tight regulation of cell proliferation. In cancer cells, activation of oncogenes and/or inactivation of tumor suppressor genes provide continuous proliferative signals in part by adjusting the state of diverse PTMs of effector proteins that are involved in regulation of cell survival, cell cycle and proliferation, leading to abnormally fast proliferation of cancer cells. In addition to dysregulated proliferation, 'altered tumor metabolism' has recently been recognized as an emerging cancer hallmark. The most common metabolic phenotype of cancer is known as the Warburg effect or aerobic glycolysis that consists of increased glycolysis and enhanced lactate production even in the presence of oxygen. Although Otto Warburg observed aerobic glycolysis nearly 90 years ago, the detailed molecular mechanisms how increased glycolysis is regulated by oncogenic and/or tumor suppressive signaling pathways remain unclear. In this review, we summarize recent advances revealing how these signaling pathways reprogram metabolism through diverse PTMs to provide a metabolic advantage to cancer cells, thereby promoting tumor cell proliferation, tumorigenesis and tumor growth.
引用
收藏
页码:4279 / 4285
页数:7
相关论文
共 50 条
  • [41] Urinary Proteins with Post-translational Modifications
    Liu, Liu
    Liu, Xuejiao
    URINE PROTEOMICS IN KIDNEY DISEASE BIOMARKER DISCOVERY, 2015, 845 : 59 - 65
  • [42] Post-Translational Modifications of Extracellular Proteasome
    Tsimokha, Anna S.
    Artamonova, Tatiana O.
    Diakonov, Egor E.
    Khodorkovskii, Mikhail A.
    Tomilin, Alexey N.
    MOLECULES, 2020, 25 (15):
  • [43] Post-translational protein modifications in schizophrenia
    Mueller, Toni M.
    Meador-Woodruff, James H.
    NPJ SCHIZOPHRENIA, 2020, 6 (01):
  • [44] Supramolecular sensing of post-translational modifications
    Waters, Marcey
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [45] Novel post-translational modifications in cancer
    Li, Dongling
    Cai, Qinrui
    Li, Li
    Chen, Yao
    Lin, Ling
    Zhou, Xiaoya
    Lin, Jianshan
    Yang, Fan
    ONCOLOGIE, 2025, 27 (01) : 3 - 14
  • [46] Post-translational modifications by NMR spectroscopy
    Theillet, F-X.
    Liokatis, S.
    Selenko, P.
    FEBS JOURNAL, 2014, 281 : 10 - 10
  • [47] The Next Frontier of Post-Translational Modifications
    Martin, Brent R.
    BIOPOLYMERS, 2014, 101 (02) : 131 - 132
  • [48] POST-TRANSLATIONAL MODIFICATIONS Panning for phosphohistidine
    Piggott, Matthew J.
    Attwood, Paul V.
    NATURE CHEMICAL BIOLOGY, 2013, 9 (07) : 411 - 412
  • [49] POST-TRANSLATIONAL MODIFICATIONS IN THE BIOSYNTHESIS OF COLLAGEN
    KIVIRIKKO, KI
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1982, 363 (09): : 878 - 878
  • [50] Designer proteases for post-translational modifications
    Strack, Rita
    NATURE METHODS, 2017, 14 (02) : 106 - 107